b'Thursday Nov 1 1 Please note that the times are listed in GST , Gulf Standard Time (UTC +4 hours)World Urological Oncology13351510Federation (WUOF) Symposium SESSION 3 Kidney CancerCo-Chairs Population Screening for Kidney CancerPeter Hammerer, GermanyGrant Stewart, United KingdomLaurence Klotz, Canada Surgical Insights for Management of Non-Clear Histology of RCC10101230Gennady Brataslavsky, United StatesSESSION 2 Bladder Cancer Molecular Biomarkers in RCC and Personalized Genomics of Bladder Cancer TherapyAlexandre Zlotta, Canada Anil Kapoor, CanadaSexual Dimorphism in Bladder Cancer - Current Status of Cytoreductive Nephrectomy in Implications for Management the IO Era Rob Siemens, Canada Ricardo Rendon, CanadaTri-modal Therapy for MIBC: Role of Immune Checkpoint Inhibitor Combination the Urologic Oncologist Therapy in Primary Metastatic Clear-Cell RCCAdam Feldman, United States Axel Bex, United KingdomProteogenomics and Predicting Sensitivity toNephrectomy in the Treatment Sequence of Chemotherapy Metastatic RCCSeth Lerner, United States Peter Mulders, the NetherlandsRegionalization of Bladder Cancer Care DiscussionGirish Kulkarni, CanadaCombined Radiation with Checkpoint Inhibitors in Bladder CancerWassim Kassouf, CanadaBladder and Upper Tract Urothelial CancerFraternal Twins or Distant Cousins Peter Black, CanadaDiscussion12 BROADCAST SCHEDULE SIU@U 2021'